癌症转移的演变通过血统转基因差异化
Yu Xiao1,2, Wan Jin1,2, Fangjin Chen3
1Department of Biological Repositories, Human Genetic Resources Preservation Center of Hubei Province, Laboratory of Precision Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Research (Washington, D.C.)
|February 23, 2026
概括
癌细胞可以通过转基因分化改变其身份,这是转移至关重要的过程. 这种与MAPK信号相关的表观遗传重编程,为预防癌症扩散提供了新的治疗点.
科学领域:
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 细胞分化 细胞分化
背景情况:
- 虽然基因突变在癌症中得到了很好的研究,但驱动转移的非遗传机制不太了解.
- 癌症转移通常与原发性瘤共享突变特征,这表明传播的替代驱动因素.
研究的目的:
- 调查血统跨差异化作为癌症转移的一个机制的作用.
- 阐明转移性进化背后的表观遗传和转录性变化.
主要方法:
- 开发生物信息工具,用于单细胞分辨率重建癌症表型演变.
- 在转移性进展期间对转录和表观基因组谱系忠实的分析.
- 转差异化与临床数据 (病原学等级,存活率) 和信号通路的相关性.
主要成果:
- 癌细胞逐渐失去血统忠诚,在转移前进化过程中降低分化,变成胎儿状的状态.
- 从这种状态的重新分化导致转基因分化的转移性细胞,这是人类和小鼠模型中的一个关键特征.
- 转基因差异化与预后不佳相关,并与激活的线粒激活蛋白激酶 (MAPK) 信号相关.
结论:
- 由表观遗传重编程驱动的血统跨差异化是癌症转移的一个基本机制.
- 激活的MAPK信号促进了转基因分化和转移.
- 通过MAPK抑制逆转转差异化是一种潜在的治疗策略,可以防止癌症扩散.
相关概念视频
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Forced Transdifferentiation
2.4K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
2.4K
Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K


